NCT00000345已完成1 期
Evaluation of Lofexidine for Treatment of Opiate Withdrawal
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Opiate withdrawal
研究概览
简要总结
The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •M/F ages 21-
- •Meet DSM-IV criteria for opiate dependence. Agree to conditions of the study and sign informed consent.
排除标准
- •Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.
结局指标
主要结局
Opiate withdrawal
Adverse effect measures
Craving of opiates
Liking of opiates
Efficacy of lofexidine
Euphoria
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3Opioid-Related DisordersSubstance-Related DisordersNCT00000354National Institute on Drug Abuse (NIDA)
已完成
1 期
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7Opioid-Related DisordersSubstance-Related DisordersNCT00000358National Institute on Drug Abuse (NIDA)
已完成
4 期
Lofexidine for Adults Undergoing Lumbar Spine SurgeryOpioid WithdrawalNCT04126083Mayo Clinic6
已完成
2 期
Lofexidine for Management of Opioid Withdrawal With XR-NTX TreatmentOpioid-use DisorderNCT04056182New York State Psychiatric Institute20
已完成
2 期
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1Opioid-Related DisordersNCT00142909Yale University86